The Pathology of Gastric and Duodenal Polyps
Introduction to Gastric and Duodenal Polyps
Liberal use of upper endoscopy allows for increased detection of gastric and duodenal polyps, found in approximately 6% and 4.6% of examinations, respectively.
Polyps can be neoplastic (potentially malignant) or non-neoplastic (e.g., hyperplastic).
Characteristic topographical features, endoscopic appearance, and associated mucosal pathologies (e.g., Helicobacter pylori, autoimmune gastritis) guide the evaluation of polyps.
Classifications:
Polyps arise from
Surface epithelium (foveolar/intestine type)
Deeper glandular components (e.g., pyloric/oxyntic gland derived).
Classification of Polyps
Surface Epithelium-Derived Polyps
Hyperplastic Polyps:
Most common gastric polyps, particularly in those aged 60-80.
Associated with gastritis:
Intestinal metaplasia (37%)
H. pylori infection (25%)
Chemical/Reactive gastropathy (21%).
Gastric Fundic Gland Polyps (FGPs):
Increased incidence related to proton pump inhibitors (PPIs); their incidence went from 8.8% to 66% in one study.
Adenomas:
Comprise only 1-10% of gastric polyps, with intestinal-type adenomas being the most common.
Specific Types of Gastric Polyps
Hyperplastic Polyps
Typically solitary, predominantly found in the antrum (60%).
May be broad-based, smooth, and lobulated, with sizes generally under 20 mm but capable of growing larger.
Risk of neoplastic transformation increases with size (>25 mm).
Histological Characteristics:
Irregular, elongated, tortuous pits with cystic dilations.
Foveolar epithelium with an apical neutral mucin cap seen under microscopic examination with specific staining protocols (e.g., Alcian blue staining).
May exhibit mucosal prolapse phenomenon in certain cases, especially in the antropyloric area.
Gastric Fundic Gland Polyps (FGPs)
Small, round, smooth-surfaced polyps found in oxyntic mucosa, often with a background of normal mucosa or minimal inflammation.
Diagnostic implications vary based on their association with syndromes (e.g., FAP, GAPPS).
Adenomas
Two histological types: Intestinal-type (56%) and Foveolar-type (41%).
Pathological features of intestinal adenomas resemble those of colonic adenomas and typically arise from regions with chronic changes (gastritis).
Endoscopic and histological management considerations advised based on size and dysplasia.
Diagnosis and Management Strategies
Assess surrounding mucosa: Essential for accurate diagnosis as polyps are frequently associated with adjacent pathologies, including chronic gastritis and H. pylori infection.
Management strategies vary:
Endoscopic resection recommended for polyps >10 mm or those with dysplastic changes; smaller lesions may be monitored.
Regular follow-ups after resection to monitor for recurring lesions or malignant transformations.
Duodenal Polyps
Located mainly within the ampullary region with a significant association with FAP and MAP syndromes.
Most duodenal polyps identified are adenomatous, and pathological characteristics similar to colonic adenomas are common.
Duodenal Gastric Heterotopia and Brunner Gland Hyperplasia:
Distinct from adenomatous lesions and non-neoplastic hyperplastic nodules; maintenance of lobular architecture can aid diagnosis.
Syndromes Associated with Polyps
Various genetic syndromes lead to the development of gastric and duodenal polyps:
Familial Adenomatous Polyposis (FAP): Associated with FGPs and duodenal adenomas, presenting significant cancer risk in aged populations.
Peutz-Jeghers Syndrome: Presents hamartomatous polyps with gastrointestinal and extra-intestinal manifestations.
Cowden Syndrome: Related to multiple hamartomatous polyps, requiring careful management.
Summary
Emerging management guidelines highlight the importance of early detection and classification of gastric and duodenal polyps for preventive healthcare.
Continuous research and surveillance are critical for understanding inheritance patterns, managing risks, and improving patient outcomes regarding polyp-associated malignancies.